EDTUTC-4 New YorkLog in Sign up

RNAZ
TransCode Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 20, 2026 3:30:03 PM EDT

1.67USD-1.765%(-0.03)19,929

1.3800Bid1.9700Ask0.5900Spread

RNAZ News

Day breaks

08:04 AM EDTTransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026 ·

PR Newswire

04:16 PM EDTTransCode Therapeutics makes $840,975 prepayment under convertible notes agreement ·

Investing.com

08:04 AM EDTTransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology ·

PR Newswire

08:41 PM EDTTransCode Therapeutics, Inc. (RNAZ) Discusses Advancing Multi-Platform Oncology Pipeline Targeting Metastatic Cancer Transcript ·

Seeking Alpha